NYSEHealth CareMedical DevicesSnapshot 2026-07-23
Reading OWLT? Create a free portfolio, then add this holding for ongoing Reports and tracking. Track it in a free portfolio. No credit card.
Create your account →A long-form read on the 1–3 year hold thesis. Slower and deeper than the daily snapshot — it refreshes only when the evidence moves.
This investment represents a turnaround story with a medium confidence level. OWLT is currently loss-making, and while it has set ambitious targets, recent performance has been weak, making the outlook uncertain.
The market seems to have priced in a low expectations gap, suggesting that investors are not overly optimistic about OWLT's near-term prospects. Valuation appears cheap compared to peers, but there is a divergence in expectations.
Management has set targets for adjusted EBITDA and revenue growth, but progress has been mixed. The recent financial performance has been weak, and there is a notable risk of missing future earnings expectations.
The long-term thesis hinges on the performance of sector bellwethers like ABT, SYK, and MDT. If these companies continue to perform well, it could provide a favorable backdrop for OWLT. Conversely, any negative guidance from these peers could impact OWLT's momentum.
In the next 1 to 3 years, OWLT's performance will depend on its ability to meet management's targets and the overall health of the healthcare sector. Not investment advice.
The most important moves since the prior daily snapshot.
No, our read on the company is unchanged. The financial performance remains weak, which is consistent with its recent history, and there are no new threats or supports that alter the current thesis. The market backdrop has seen fluctuations, but these do not directly impact the company's standing at this time.
as of 2026-07-23
Specific, dated things to watch for, each with what would confirm it and what would prove it wrong.
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.
Why it matters: The earnings report will give important updates. It will cover financial performance and future plans.
Confirms one read:Earnings report shows positive trends in revenue and margins.
Confirms the other:The earnings report shows ongoing drops in revenue or margins.
Why it matters: This shows that Owlet may not meet its growth target. This could hurt investor trust.
Confirms:Q2 2026 revenue growth was below 12% compared to last year.
Disproves:Q2 2026 revenue growth reported at or above 12% year-over-year.
Why it matters: Achieving gross margins of 50% would show progress toward the 2026 goal. It indicates better cost management.
Confirms:Q2 gross margins reported at 50% or above.
Disproves:Q2 gross margins reported below 50%.
Why it matters: News about the buyback may show confidence in the company's value and financial health.
Confirms:They announced progress or completion of the share buyback.
Disproves:No updates or cancellation of the buyback program.
Why it matters: If health care revenue growth speeds up, it may benefit Owlet Inc. amidst sector challenges.
Confirms:Health care sector revenue growth is speeding up to 10% or more.
Disproves:Sector growth is slowing down. This affects Owlet's market position.
Why it matters: Meeting the adjusted EBITDA target shows better financial health. It also shows more efficiency.
Confirms:Adjusted EBITDA reported at $7 million or more for Q2.
Disproves:Adjusted EBITDA was below $7 million for Q2.
Why it matters: Hitting this target would mean Owlet is making more money and working better.
Confirms:Adjusted EBITDA was $7 million or more for 2026.
Disproves:Adjusted EBITDA was less than $7 million for 2026.
Why it matters: Lower gross margins could mean higher costs or pricing issues. This affects Owlet's profits.
Confirms:Gross margins reported below 50% for 2026.
Disproves:Gross margins reported at or above 50% for 2026.
Why it matters: More subscriptions would show strong demand for Owlet's services. This could lead to more money.
Confirms:Owlet360 subscription service has more than 115,000 paying subscribers.
Disproves:Owlet360 subscription service fails to grow beyond 115,000 paying subscribers.
